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High-resolution ‘H NMR spectra at 300 MHz of the polypeptide cardiac stimulants anthopleurin-A and 
Anemonia sulcata toxin II reveal conformational heterogeneity in both molecules. The two conformations, 
manifest in a number of split ‘H resonances, are in slow exchange over a wide range of pH and 
temperature. Heterogeneity affects a region of these molecules containing the structurally and functionally 
important Asp residues. By comparison with a homologous polypeptide Anemonia sulcata toxin I, which 
does not show this type of heterogeneity, it is suggested that the heterogeneity may originate in cis-trans 
isomerism of the Gly-40 to Pro-41 peptide bond. 
Cardiotonic agent Neurotoxin 
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1. INTRODUCTION 
Sea anemones contain a number of polypeptides 
of M, -5000, which exhibit strong cardiac 
stimulatory activity. The best characterised of 
these are AP-A2 from Anthopleura xanthogram- 
mica [l] and ATX II from Anemonia sulcata [2,3], 
which share extensive sequence homology (fig. 1). 
These polypeptides appear to act by delaying inac- 
tivation of the cardiac Na+ channel [4], thus pro- 
longing the fast inward Na+ current and increasing 
the force of cardiac contraction. Because of their 
potency in this respect their pharmacological and 
electrophysiological properties are being extensive- 
ly studied. However, little is known about their 
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structure in solution. AP-A and ATX II have been 
investigated by a range of spectroscopic techniques 
[5,6], and their overall structures and ionisation 
behaviour have been compared using 13C NMR 
spectroscopy [7-91. However, more detailed struc- 
tural information is required as a basis for 
understanding their mode of action. We are carry- 
ing out high-resolution ‘H NMR studies of the 
structures of AP-A, ATX II, and the closely 
related polypeptide ATX I [lo], the sequences of 
which are shown in fig. 1. We have observed major 
conformational heterogeneity in AP-A and ATX 
II, but not ATX I. We describe these findings and 
present a possible explanation in terms of cis-trans 
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Fig. 1. Amino acid sequences of AP-A, ATX II and ATX 
I [1,31. 
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isomerism of a Pro peptide bond in the native pro- 
teins. This conformational heterogeneity may af- 
fect the cardiac stimulatory activities of these 
molecules. 
2. MATERIALS AND METHODS 
AP-A was isolated from A. xanthogrammica by 
the methods of [l] or [ll], and ATX I and II from 
An. sulcata as in [2,3]. Sample purity was checked 
by polyacrylamide gel electrophoresis (PAGE) 
both at pH 4.6 and in the presence of SDS [12]. 
Densitometer scans of the gels indicated that AP-A 
contained less than 5% impurity, while ATX II 
contained up to 18%. AP-A was also pure accord- 
ing to amino acid and N-terminal sequence ana- 
lyses. 2Ht0 (>99.75% 2H) was obtained from the 
Australian Atomic Energy Commission, Lucas 
Heights, NS\nr, and 2HC1 and Na02H from 
Merck, Sharp and Dohme, Montreal. 
Prior to NMR experiments samples were in- 
cubated in 2H~0 at room temperature and 
lyophilised, this procedure being carried out at 
least twice. pH was measured at 22°C using an Ac- 
tivon model 101 pH meter fitted with an Ingold 
microelectrode, model 6030-02. Titration curves 
were analysed by a non-linear, least-squares fit, 
assuming rapid exchange between the acidic and 
basic extremes of each ionisation. 
300 MHz ‘H NMR spectra were recorded in the 
pulsed Fourier transform mode with quadrature 
detection on a Bruker CXP-300 spectrometer in- 
corporating an Aspect 2000 computer. Spinning 
sample tubes (5 mm o.d.) were used. Probe 
temperature was 27°C. Typical acquisition 
parameters were: sweep width 3816 or 4000 Hz, 
90” RF pulse (5.4-7.3 as), 2.0 s recycle time, 8192 
time-domain addresses. Prior to Fourier transfor- 
mation, spectra were multiplied by a Lorentz- 
Gauss window function, and in most cases zero- 
filled to 32768 addresses. Chemical shifts are ex- 
pressed relative to DSS, but were measured using 
a trace of internal dioxane at 3.751 ppm downfield 
from DSS. A 2-dimensional COSY spectrum [131 
was recorded using the pulse sequence 
to-90”~tl-90’~tz, with appropriate phase cycling to 
select N-type peaks. tl was incremented 255 times 
from 0.01-67 ms, tz was 0.27 s, sweep width 
3800 Hz, and recycle time 1.5 s. Low-power ir- 
radiation of the H’HO resonance was applied con- 
16 
tinuously during the period to. Prior to Fourier 
transformation the 256 x 2048 data matrix was 
multiplied by a sine-bell function in tl and a sine- 
squared bell function in t2, and zero-filled to yield 
a 1024 x 4096 matrix. The frequency domain spec- 
trum is shown in the absolute value mode, without 
symmetrisation. 
3. RESULTS 
‘H NMR spectra of AP-A and ATX II contain 
many resonances which are split into two com- 
ponents. In the aromatic regions of their spectra, 
shown in fig.2, this is most clearly seen for the 
well-resolved H” resonances of the two His 
residues, near 8.5 ppm. In each spectrum the 
downfield H” resonance is split into two peaks, la 
and b, with intensities of -213 and l/3 of a single 
proton, respectively, in AP-A, and half a proton 
each in ATX II. The corresponding Ha resonances 
are also split, as shown by the COSY spectrum of 
AP-A in fig.3. In this spectrum the existence of 
spin-spin coupling between two protons is 
manifested in a pair of off-diagonal cross peaks 
which form two corners of a square. The other two 
Ppm 
Fig.2. Aromatic regions of 300 MHz ‘H NMR spectra of 
(A) 2 mM ATX I in ‘I&O, pH 6.8 (2240 scans); (B) 
7 mM AP-A in ‘H&, pH 4.0 (3264 scans); (C) 2 mM 
ATX II in ‘HzO, pH 4.7 (2000 scans). Other spectral 
conditions are described in section 2. 
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Fig.3. Contour plot of the 6.35-9.0 ppm region of a 
300 MHz ‘H COSY spectrum of 10 mM AP-A in ‘HzO, 
pH 4.7, 27°C. Digital resolution infl is 3.71 Hz/pt and 
in fi 1.85 Hz/pt. Spectrum was recorded in -18 h. 
Proton-proton J connectivities between His” and HissZ 
for both His are shown. 
corners, located on the diagonal, correspond to the 
chemical shifts of the two coupled protons. In fig.3 
the chemical shifts of peaks la and b are 8.61 and 
8.57 ppm, respectively, and those of their cor- 
responding H& resonances 7.33 and 7.27 ppm. At 
the pH values of figs 2 and 3, the H” and Ha 
resonances of the second His residue show little or 
no splitting, but clear splitting occurs at other pH 
values. 
Several other resonances in the aromatic and 
methyl regions of the spectra of these two polypep- 
tides show similar splittings. Low-field 13C NMR 
spectra of ATX II also showed splitting on one of 
the Trp Cy resonances [9]. The extent of these ef- 
fects, together with their observation in two 
polypeptides from different species, suggests that 
they are not due to contaminants. AP-A is pure by 
the criteria of amino acid composition, N-terminal 
sequence analysis and polyacrylamide gel elec- 
trophoresis, while ATX II contains a small amount 
of impurity. In neither case can the splittings be ac- 
counted for by impurities. 
It appears, therefore, that AP-A and ATX II ex- 
ist in two conformations in solution. In each 
molecule these two conformations are in slow 
chemical exchange over the pH range 1.4-12.8 at 
27”C, as indicated by the lack of exchange 
broadening for pairs of resonances only a few 
hertz apart (e.g., in ATX II at pH 4 sharp peaks 
3 Hz apart are observed for the two components of 
one His H” resonance, indicating that the lifetime 
of each conformation is 9 50 ms). At low pH there 
is a decrease in the fraction of one conformation in 
ATX II (e.g., at pH 1.4-1.7 the ratio of minor to 
major form is approx. 1: 2.6, compared with 1: 1.2 
at pH 4-5), but not in AP-A. At 67°C (pH 4.0) for 
AP-A and 75°C (pH 5.0) for ATX II the two con- 
formations are still in slow exchange. Clearly, 
there is a high activation energy barrier to 
interconversion. 
His-34 and -39 of APA- and ATX II are both af- 
fected by the heterogeneity. In addition, both 
residues sense the ionisation of a carboxylic group 
at low pH, and the pK, for the latter differs in the 
two conformations, as indicated in table 1. Taking 
a weighted average over the data for H” of His-34 
and Ha and H” of His-39 in AP-A, the pK, of this 
carboxylic group is 1.7 in conformation a and 2.5 
in b. Corresponding values for His-39 in ATX II 
are 1.9 and 2.3. Previous 13C NMR studies of AP- 
A [8] and ATX II [9] showed that one of the Asp 
residues (at position 7 or 9 in the sequence) has 
pKa 5 2, and that protonation of this carboxylate 
causes extensive conformational changes in AP-A 
and ATX II. The fact that this structurally impor- 
tant Asp residue exhibits different pKa values in 
the two forms indicates that its local environment 
is also affected by the heterogeneity. 
4. DISCUSSION 
The ‘H NMR data presented here indicate that 
AP-A and ATX II exhibit conformational 
heterogeneity in solution. This type of conforma- 
tional heterogeneity is not observed in ATX I (In 
ATX I methyl resonances of Met-18 and one Thr 
residue show splitting into two peaks of equal in- 
tensity [lo]. These splittings collapse at low pH or 
intermediate temperature, and have a different 
origin from the major effects observed for AP-A 
and ATX II.) (see fig, 2) Although there are many 
amino acid substitutions in ATX I, compared with 
AP-A and ATX II, we believe that the significant 
difference is the absence of Pro-41 in ATX I. 
Thus, it is possible that the peptide bond preceding 
17 
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Table 1 
Titration data for His residues of AP-A (l-2 mM, ‘HzO, 27°C) and ATX II (0.7-1.5 mM, ‘H20, 27°C) 
Resonance P&I s 0 Al 6Al--S 1 P&Z JA2 JA2 - 682 
AP-A 
His-34A H” a 
b 
HbZ a/b 
His-39 H” a 
b 
HO a 
b 
ATX II 
His-34A Hc’ a/b 
Ha a 
b 
_D 
_E 
6.91 (0.12)’ 8.475 0.971 
6.81 (0.11) 7.150 0.413F 
6.76 (0.12) 7.173 0.412F 
His-39 Hf’ a 1.95 (0.17) 8.511 -0.123 6.46 (0.09) 
b 2.36 (0.19) 8.406 -0.150 6.50 (0.06) 
Ha a 1.9 (0.2 ) 7.146 -0.176 _n 
b 2.21 (0.15) 7.015 - 0.240 _e 
1.5 (0.3 ) 
2.6 (0.3 ) 
2.3 (0.3 )’ 
1.8 (0.3 ) 
2.27 (0.16) 
1.8 (0.3 ) 
2.7 (0.2 ) 
8.524 
8.498 
7.091 
8.603 
8.483 
7.267 
7.218 
0.070 
0.045 
- 0.050 
- 0.036 
- 0.099 
- 0.075 
- 0.065 
6.90 (0.09)’ 
6.82 (0.13)’ 
6.65 (0.10) 
6.71 (0.08) 
6.65 (0.11) 
6.77 (0.08) 
8.456 0.941 
7.141 0.356 
8.638 0.988 
8.587 0.938 
7.339 0.400 
7.284 0.345 
8.637 0.988 
8.556 0.907 
A Residue numbering system for AP-A is used (fig.1) 
B Values in parentheses are standard deviations 
’ Average value for forms a and b 
D Peak moves downfield slightly at pH < 4 and splits into two components 
E Peak overlap and uncertainties about crossover prevent accurate pK, determinations 
F Analysed assuming no crossover of peaks during titration. Peak crossover would change values fo 0.389 and 0.436, 
respectively, with no effect on pK, or 6~ 
Pro-41 in AP-A and ATX II can exist in either the 
cis or truns configuration in the native proteins. 
Many biologically active peptides contain 
equilibrium mixtures of cis and lrans peptide 
bonds preceding Pro residues, and some native 
proteins, e.g., ribonuclease A and subtilisin, con- 
tain cis Pro residues [14]. However, we know of 
only one example of conformational heterogeneity 
in a native, globular protein ascribed to cis-tram 
isomerism of the peptide bond preceding a Pro 
residue, viz., the Leu-20 to Pro-21 bond in 
dihydrofolate reductase [151. 
Some support for the proposition that confor- 
mational heterogeneity in AP-A and ATX II 
originates in the Gly-40 to Pro-41 peptide bond 
comes from the effects on the His Ha and H” 
resonances. In each polypeptide, the downfield 
Ha and H” resonances how greater splitting than 
their upfield counterparts. From analysis of 
nuclear Overhauser enhancement studies and 
ionisation behaviour, the downfield Ha and H” 
resonances are assigned to His-39 and the upfield 
resonances to His-34 (unpublished). The greater 
splitting of both the Ha and H” resonances of 
His-39 compared with His-34 is consistent with 
heterogeneity in the Gly-40 to Pro-41 peptide bond 
conformation being the cause of the splittings. 
Conformational heterogeneity in AP-A and 
ATX II, whatever its origin, is of interest not just 
from the standpoint of protein structure, but 
because this heterogeneity affects residues thought 
to be essential for cardiac stimulatory activity. 
His-39 has been proposed to be part of the ‘active 
site’ of AP-A [l]. In addition, arguments based on 
chemical modification studies and 13C NMR data 
[7-91 indicate that one or both Asp residues are 
essential for activity. As the local environments of 
these functionally important residues are affected 
by heterogeneity, it is likely that cardiac 
stimulatory activity is also affected. 
18 
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